AKTX
Akari Therapeutics
AKTX
AKTX
13 hedge funds and large institutions have $5.25M invested in Akari Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$315K | |
| 2 | +$68K | |
| 3 | +$8.31K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$3.02K |
| 5 |
FIA
FNY Investment Advisers
New York
|
+$403 |
Top Sellers
| 1 | -$115K | |
| 2 | -$58K | |
| 3 | -$33.7K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$30.3K |
| 5 |
Millennium Management
New York
|
-$16.2K |